Bandingkan Harga & Kinerja Indosat Tbk. (ISAT) vs Tempo Scan Pacific Tbk. (TSPC)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Indosat Tbk. dan Tempo Scan Pacific Tbk.: Indosat Tbk. diperdagangkan di Rp2.430 (kapitalisasi pasar 77,4 T, volume 24 jam 93,15 jt), sedangkan Tempo Scan Pacific Tbk. diperdagangkan di Rp2.730 (kapitalisasi pasar 12,36 T, volume 24 jam 1,41 jt). Perbedaan utamanya: Indosat Tbk. jauh lebih besar — sekitar 6,3× kapitalisasi pasar Tempo Scan Pacific Tbk., dan Indosat Tbk. lebih aktif diperdagangkan (93,15 jt vs 1,41 jt). Mana yang lebih baik tergantung tujuan investasimu.
| ISAT | TSPC | |
|---|---|---|
Kapitalisasi Pasar | 77,4 T | 12,36 T |
Volume | 93,15 jt | 1,41 jt |
Lot | 931,49 rb | 14,08 rb |
Perputaran | 223,55 M | 3,83 M |
Harga Rata-rata | 2.399,91 | 2.722,04 |
Nilai Transaksi | 223,55 M | 3,83 M |
Harga Ekuilibrium Indikatif | 2.430 | 2.730 |
Volume Ekuilibrium Indikatif | 38,19 rb | 2,51 rb |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Indosat Tbk.
Indonesian Satellite Corporation Tbk, PT (Persero), was established on November 10, 1967 within the framework of the Indonesian foreign Investment Law No. 1 of 1967. The company’s articles of association have been amended from time to time, most recently on Sept 4, 1997, concerning the changes in the articles of association to conform with Law No. 1 of 1995 on limited liability companies.
Selengkapnya di halaman ISAT →Tentang Tempo Scan Pacific Tbk.
PT. Tempo Scan Pacific Tbk (the Company) was established in the Republic of Indonesia dated 20 May 1970, under its original name PT Scanchemie within the framework of the Domestic Capital Investment Law No. 6 year 1968, as amended by Law No. 12 year 1970, based on Notarial Deed No. 37 of Ridwan Suselo, S.H. The company is famous for such pharmaceutical products as Bodrex, Hemaviton and Neo-Rheumacyl.
Selengkapnya di halaman TSPC →
